Haemonetics Corp. (hae 0 03/01/26)

13F holders, Q1 2024 (March 31)
7holders
$0.92avg. 13F price*

At the end of Q1 2024, 7 institutions reported holding Haemonetics Corp. (hae 0 03/01/26) in their 13F filings. The largest holders were New York State Common Retirement Fund ($6.1M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($5.5M) and Toronto Dominion Bank ($2.8M).

Company
Haemonetics Corp. (hae 0 03/01/26)
CUSIP
405024AB6
Latest filing quarter
Q4 2025

History

Number of 13F holders

051015 Q1 2024: 7Q1 2024Q2 2024: 6Q2 2024Q3 2024: 10Q3 2024Q4 2024: 9Q4 2024Q1 2025: 8Q1 2025Q2 2025: 9Q2 2025Q3 2025: 10Q3 2025Q4 2025: 11Q4 2025

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions0$0
Exits1$36K

Ownership 7 holders

New York State Common Retirement Fund 0.01% Add +38.6% 6,624,000 $6.1M
BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.01% No change 6,000,000 $5.5M
Toronto Dominion Bank 0.00% Reduce -25.0% 3,000,000 $2.8M
Sei Investments Co. 0.00% No change 335,000 $308K
Bank of New York Mellon Corp 0.00% No change 300,000 $276K
Oppenheimer Asset Management Inc. 0.00% Reduce -49.6% 130,000 $119K
Stephens Inc. 0.00% Add +43.9% 118,000 $108K

"% of holder's portfolio" is HAEMONETICS CORP (HAE 0 03/01/26)'s weight in each manager's 13F, not the share of Haemonetics Corp. (hae 0 03/01/26) the manager owns.